Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis

Cell Cycle

Volumn 7, Issue 9, 2008, Pages 1197-1204

  Antoch, Marina P ^a   Gorbacheva, Victoria Y ^b   Vykhovanets, Olena ^b   Toshkov, Illia A ^c   Kondratov, Roman V ^d   Kondratova, Anna A ^b   Lee, Choogon ^e   Nikitin, Alexander Yu ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d CLEVELAND STATE UNIVERSITY   (United States)

^e FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Carcinogenesis; Circadian; CLOCK BMAL1 transcriptional complex; Ionizing radiation

Indexed keywords

HEAT SHOCK PROTEIN; PER1 PROTEIN; PROTEIN BMAL1; PROTEIN TIMELESS; TRANSCRIPTION FACTOR CLOCK;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CIRCADIAN RHYTHM; DOWN REGULATION; FEMALE; GAMMA RADIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; HISTOPATHOLOGY; LIFESPAN; MALE; MOLECULAR CLOCK; MOUSE; NONHUMAN; PHENOTYPE; RADIATION DOSE; SOMATIC HYPERMUTATION; TRANSCRIPTION INITIATION;

MAMMALIA; MUS;

EID: 44349107666     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.9.5886     Document Type: Article

References (39)

1. Schibler U, Sassone Corsi P. A web of circadian pacemakers. Cell 2002; 111:919-22.
2. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002; 109:307-20.
3. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Human molecular genetics 2006; 15:271-7.
4. Kondratov RV, Gorbacheva VY, Antoch MP. The role of mammalian circadian proteins in normal physiology and genotoxic stress responses. Current topics in developmental biology 2007; 78:173-216.
5. Haus E, Smolensky M. Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes Control 2006; 17:489-500.
6. Rafnsson V, Sulem P, Tulinius H, Hrafnkelsson J. Breast cancer risk in airline cabin attendants: a nested case-control study in Iceland. Occup Environ Med 2003; 60:807-9.
7. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001; 12:95-101.
8. Filipski E, Li XM, Levi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control 2006; 17:509-14.
9. Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, Ben David Y. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell cycle phases. The American journal of pathology 2001; 158:1793-801.
10. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111:41-50.
11. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science (New York, NY) 2003; 302:255-9.
12. Gauger MA, Sancar A. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 2005; 65:6828-34.
13. Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch JB, Takahashi JS. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci USA 2007; 104:3342-7. Epub 2007.
14. Kondratov RV, Antoch MP. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends in cell biology 2007; 17:311-7.
15. Vitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, McDonald JD, Dove WF, Pinto LH, Turek FW, Takahashi JS. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 1994; 264:719-25.
16. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science (New York, NY) 2005; 308:1043-5.
17. Vitaterna MH, Ko CH, Chang AM, Buhr ED, Fruechte EM, Schook A, Antoch MP, Turek FW, Takahashi JS. The mouse Clock mutation reduces circadian pacemaker amplitude and enhances efficacy of resetting stimuli and phase-response curve amplitude. Proceedings of the National Academy of Sciences of the United States of America 2006; 103:9327-32.
18. Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, Antoch MP. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proceedings of the National Academy of Sciences of the United States of America 2005; 102:3407-12.
19. Besplug J, Burke P, Ponton A, Filkowski J, Titov V, Kovalchuk I, Kovalchuk O. Sex and tissue-specific differences in low-dose radiation-induced oncogenic signaling. Int J Radiat Biol 2005; 81:157-68.
20. Kovalchuk O, Ponton A, Filkowski J, Kovalchuk I. Dissimilar genome response to acute and chronic low-dose radiation in male and female mice. Mutat Res 2004; 550:59-72.
21. Ward J, Anver M, Mahler J, Devor Henneman D. Pathology of mice commonly used in genetic engineering (C57BL/6; 129; B6,129; and FVB/N). In: Ward J, Mahler J, Maronpot R, Sundberg J, eds. Pathology of genetically engineered mice. Ames: Iowa State University Press 2000; 161-79.
22. Mohr U. Pathobiology of Aging Mouse. In: Mohr U, Dungworth D, Capen C, Carlton W, Sundberg J, Ward J, eds. Washington: ILSI Press 1996.
23. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP. Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 2006; 20:1868-73.
24. Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int 2002; 19:237-51.
25. Levi F. Chronopharmacology of anticancer agents. Handbook of Experimental Pharmacology. Berlin: Springer-Verlag 1997; 299-331.
26. Krugluger W, Brandstaetter A, Kallay E, Schueller J, Krexner E, Kriwanek S, Bonner E, Cross HS. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer research 2007; 67:7917-22.
27. Yeh KT, Yang MY, Liu TC, Chen JC, Chan WL, Lin SF, Chang JG. Abnormal expression of period 1 (PER1) in endometrial carcinoma. The Journal of pathology 2005; 206:111-20.
28. Gery S, Komatsu N, Kawamata N, Miller CW, Desmond J, Virk RK, Marchevsky A, McKenna R, Taguchi H, Koeffler HP. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin Cancer Res 2007; 13:1399-404.
29. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang X, Wang Z, Ding JM. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer gene therapy 2007; 14:815-8.
30. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, Takahashi JS, Weitz CJ. Role of the CLOCK protein in the mammalian circadian mechanism. Science (New York, NY) 1998; 280:1564-9.
31. Kondratov RV, Chernov MV, Kondratova AA, Gorbacheva VY, Gudkov AV, Antoch MP. BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes & development 2003; 17:1921-32.
32. Kondratov RV, Shamanna RK, Kondratova AA, Gorbacheva VY, Antoch MP. Dual role of the CLOCK/BMAL1 circadian complex in transcriptional regulation. Faseb J 2006; 20:530-2.
33. DePinho RA. The age of cancer. Nature 2000; 408:248-54.
34. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. The international journal of biochemistry & cell biology 2002; 34:1401-14.
35. Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, Sutherland A, Thorner M, Scrable H. Modulation of mammalian life span by the short isoform of p53. Genes & development 2004; 18:306-19.
36. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415:45-53.
37. Antoch MP, Song EJ, Chang AM, Vitaterna MH, Zhao Y, Wilsbacher LD, Sangoram AM, King DP, Pinto LH, Takahashi JS. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell 1997; 89:655-67.
38. King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, Antoch MP, Steeves TD, Vitaterna MH, Kornhauser JM, Lowrey PL, Turek FW, Takahashi JS. Positional cloning of the mouse circadian clock gene. Cell 1997; 89:641-53.
39. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science (New York, NY) 2004; 304:596-600.